Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, n3m3sis
Search This Board: 
Last Post: 8/21/2017 11:23:59 AM - Followers: 136 - Board type: Free - Posts Today: 1


Pluristem Therapeutics Inc. (Nasdaq: PSTI)




Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172


CIK:  0001158780


Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 



Clinical Program:

Recent News and Press:






Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501


Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America




All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: U.S. Department of Defense to Conduct Studies of Pluristem’s PLX-R18 in a New ARS Project for Use Before Radiation Exposure... 08/16/2017 07:30:00 AM
PSTI News: Israeli Government to Support Pluristem’s Marketing Activity in China – Ministry of Economy Awards Company “Smart Money... 08/09/2017 07:00:00 AM
PSTI News: New Data from ARS Study Shows Significant Hematological Deficiencies Even at Low Radiation Levels; PLX-R18 Supports Hematolog... 07/26/2017 01:00:00 PM
PSTI News: Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40 Active Sites by the E... 07/10/2017 07:00:00 AM
PSTI News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 07/07/2017 08:33:53 AM
#6576   This Incredibly Important Piece Of Information, (Quote Below).. FDApproved 08/21/17 11:23:59 AM
#6575   How the Government Will Pay Companies to Develop FDApproved 08/20/17 08:00:14 PM
#6574   Back In January-2017....Fukushima Medical University Partners with South FDApproved 08/20/17 06:48:53 PM
#6573   Blue, Not That Huge, 150,000 Shares Traded On FDApproved 08/20/17 06:09:49 PM
#6572   The Large Amounts Of PLX-R18 Human Data In FDApproved 08/20/17 06:07:52 PM
#6571   Huge Volume, PPS Up 2.20% TASE Today..... bluehorsesho 08/20/17 05:07:20 PM
#6570   Pluristem Therapeutics Deploys Medidata’s Cloud Technology. FDApproved 08/20/17 12:42:38 PM
#6569   United states department of health and human services bluehorsesho 08/20/17 11:39:25 AM
#6567   PLX-R18 Listed as Essential Medicine by WHO ??? bluehorsesho 08/20/17 11:04:27 AM
#6566   Large-scale international emergency exercise evaluating response to a bluehorsesho 08/20/17 10:57:04 AM
#6565   96 Million OS with another 62 Million coming...... bluehorsesho 08/19/17 06:51:24 PM
#6564   “We do a lot of research in addition FDApproved 08/19/17 03:56:29 PM
#6563   Never Forget This Fact ! FDApproved 08/19/17 02:35:34 PM
#6562   This Primate Study Was Done To Gather Data FDApproved 08/19/17 02:26:33 PM
#6561   AFRRI Medical Countermeasures bluehorsesho 08/19/17 12:24:50 PM
#6560   Pioneering AFRRI research on the use of growth bluehorsesho 08/19/17 12:19:59 PM
#6559   They Just Raised Their Price Target By .50 FDApproved 08/18/17 06:27:37 PM
#6558   What would IPO be worth on Monday for Pluristem... bluehorsesho 08/18/17 06:20:11 PM
#6557   Precisely n3m3sis... They Have Been Dosing Ca FDApproved 08/18/17 05:52:32 PM
#6556   ok, so worst case it takes another 18 months.... bluehorsesho 08/18/17 05:29:09 PM
#6555   That is a very good point FDA. n3m3sis 08/18/17 05:23:30 PM
#6554   This Market Will Make The Global ARS FDApproved 08/18/17 05:09:59 PM
#6553   I agree, they have cutting edge technology without a.... bluehorsesho 08/18/17 04:53:09 PM
#6552   I believe that they do Blue. n3m3sis 08/18/17 04:38:39 PM
#6551   $$$ Contracts vs Dilution...... bluehorsesho 08/18/17 04:32:24 PM
#6550   They Are All Ready For The Big Paradigm FDApproved 08/18/17 04:11:04 PM
#6549   Well Stated zzaatt ! IMO Big Things Are zzaatt 08/18/17 03:28:57 PM
#6548   Quick, somebody tell Zami, he thinks they don't.... bluehorsesho 08/18/17 03:19:50 PM
#6547   Yes, Do Not Tell Anyone, But Here Is FDApproved 08/18/17 03:11:19 PM
#6546   BARDA will decide by EOY for the $30 million..... bluehorsesho 08/18/17 02:52:41 PM
#6545   Well Stated zzaatt ! IMO Big Things Are FDApproved 08/18/17 02:39:51 PM
#6543   DoD Has Already Confirmed They Are Doing The FDApproved 08/18/17 02:00:56 PM
#6542   $30 million for the study, Dilution....... zzaatt 08/18/17 01:44:26 PM
#6541   that I do not know, but I would think.... bluehorsesho 08/18/17 01:00:38 PM
#6540   Given the current geopolitical tensions between the US n3m3sis 08/18/17 12:41:14 PM
#6539   $30 million for the study, Dilution....... bluehorsesho 08/18/17 12:33:00 PM
#6538   New Article Just Out......ARS News bluehorsesho 08/18/17 12:11:50 PM
#6532   Eclipse is here, show me the $ and bluehorsesho 08/17/17 09:15:03 PM
#6529   I am not sure why they don't see bluehorsesho 08/17/17 07:25:30 PM
#6528   YES, for sure until $$$ comes in, ignore works.... bluehorsesho 08/17/17 06:45:32 PM
#6527   Thanks Doug ! Zami Did Say: Both ARS FDApproved 08/17/17 06:34:49 PM
#6526   H2 just started six weeks ago.... D theG 08/17/17 06:30:08 PM
#6525   thank you for that, it was a rough bluehorsesho 08/17/17 06:29:22 PM
#6523   Not sure about your timeline, Federal fiscal 2018 D theG 08/17/17 06:26:51 PM
#6522   why does bad management always ruin a good company.... bluehorsesho 08/17/17 06:22:17 PM
#6521   so another 2 years before DOD decides? Dilution 100%.... bluehorsesho 08/17/17 05:55:41 PM
#6515   Neulasta..70 Billion In Life-Time Sales ! PLX-R18 May FDApproved 08/17/17 02:33:04 PM
#6514   Neulasta is On The List !!! Hello FDApproved 08/17/17 02:04:42 PM
#6513   The U.S. Department of Defense’s (DOD) Armed Forces FDApproved 08/17/17 01:26:07 PM
#6512   Thursday...HC Wainwright Reaffirms “Buy” Rating for Pluristem Therapeutics FDApproved 08/17/17 01:17:44 PM